Steven M. Rauscher

Steven M. Rauscher discloses dealings in 2 companies, chiefly Acorda Therapeutics Inc and Oscient Pharmaceuticals Corp. Over a trading history stretching from 27 February 2006 to 15 May 2018, the count stands at 19 filings.

In open-market terms, that means 5 purchases worth €20k on one side and 5 sales worth €1.3M on the other. Netting one side against the other leaves €1.3M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants and 5 option exercises. In 2018 alone, the filings show no purchases and 1 sale.

The median purchase comes to €2,564.

The record was last updated on 17 May 2018 with an open-market sale (€208k) in Acorda Therapeutics Inc. The last purchase on record was published on 14 September 2007, which is 6,980 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.